Royalty Pharma

RPRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$33.603 B

$58.44 +0.05%

Close of 21 Sept 2026

Revenue

$2.38B

#1048 by revenue

Earnings

$770.9M

#471 by earnings

Shares outstanding

557,352,000

Latest filing cover page

P/E ratio

43.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#16Teva Pharmaceutical IndustriesTEVA$46.7B
#17BeOne MedicinesONC$41.6B
#18Royalty PharmaRPRX$33.6B
#19Alnylam PharmaceuticalsALNY$32.7B
#20ZoetisZTS$29.5B

What if Royalty Pharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$52,650.42

Per share 901× higher

Bitcoin $1.72T

$2,990.96

Per share 51.2× higher

Nvidia $5.48T

$9,530.17

Per share 163× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Royalty Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.